Idiopathic Pulmonary Fibrosis Registry China Study

Idiopathic Pulmonary Fibrosis Registry China Study

By mean of registry of newly diagnosed Chinese IPF patients from more than 15 sites, this study aims to build IPF prospective cohort, set up normative clinical database and a biological specimen bank, and examine the clinical characteristics of newly diagnosed Chinese IPF patients, as well as the nature history, prognosis, comorbidities and complications of IPF patients in China, the current treatment pattern, burden of illness, and quality of life of Chinese IPF patients.

Inclusion Criteria:

• Physician diagnosed IPF during the last 3 months based upon ATS/ERS/JRS/ALAT guidelines 2011
• Aged 40 years and above at recruitment
• Willing and able to sign an informed consent

Exclusion Criteria:

• Inclusion in any interventional clinical trials
• Lung transplantation expected within the next 6 months.